CancerLinQ LLC, a wholly owned nonprofit subsidiary of ASCO, has named three new members to its leadership team. David Dornstreich, Robert Merold, and Jennifer L. Wong recently joined CancerLinQ LLC and, in their various roles, will be utilizing their extensive strategic experience to fully realize CancerLinQ’s goal of unlocking real-world patient-care data from millions of electronic health records and securely process and analyze the data to provide immediate quality feedback and personalized insights.
“We’re building a team of uniquely talented professionals to advance this big-data initiative,” said CancerLinQ CEO Kevin Fitzpatrick. “These three new team members will be leading our alliances throughout the oncology community. These collaborations are critical to achieving CancerLinQ’s goals of inclusiveness, engagement, and collegial exchange.”
David Dornstreich
David Dornstreich
Mr. Dornstreich, who will serve as Chief of Corporate Engagement, has more than 25 years of informatics experience with life science manufacturers, health information technology, and advanced analytic organizations, as well as primary and secondary health-care research groups. Prior to joining the CancerLinQ team, he spent 5 years at the American College of Cardiology (ACC) leading data-commercialization efforts, including developing partnerships with Symphony Health Solutions and the National Heart Center of Singapore. Additionally, Mr. Dornstreich has successfully built and led sales and consulting teams at regional and national levels for a number of pharmaceutical manufacturers and market intelligence firms and was one of the pioneers in developing and commercializing longitudinal patient-level data while leading the business development team at Verispan.
Robert Merold
Robert Merold
Mr. Merold, who will serve as CancerLinQ’s Chief of Strategic Marketing, brings more than 25 years’ experience in health-care data, analytics, and enabling technologies. In the 1990s, he developed and led the core information product suite for IMS Health still used today by all major Life Science companies, first in the United States and then 27 countries around the globe. He then ran successful start-ups in genomic/proteomic informatics. For the past decade, he has consulted for a wide variety of organizations, most recently focused on applications of electronic medical record data, unstructured clinical data mining—including the IBM Watson oncology efforts—and working with medical society registries. Prior to working in the health-care sector, Mr. Merold was a senior marketing and product executive at Procter & Gamble and Bristol-Myers Squibb.
Jennifer L. Wong
Jennifer L. Wong
Ms. Wong, CancerLinQ’s new Chief of Strategic Alliances, will establish and build relationships with key stakeholders, including other health-care societies, governmental agencies, advocacy groups, oncology thought leaders, and innovation catalysts. Prior to joining CancerLinQ, she served as the Director of Strategic Innovation and Clinical Ventures at the ACC and was the Managing Director of the Diabetes Collaborative Registry, creating the first global, real-world, multispecialty, big-data diabetes initiative with leading international academic, industry, and professional association partners from across the care continuum, and the PINNACLE Registry, the largest ambulatory cardiovascular quality-improvement registry in the United States. ■
